|
Volumn 128, Issue 3, 2000, Pages 379-385
|
The role of surrogate outcome measures in evaluating medical devices
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLOSEQUINAN;
MILRINONE;
PIPERANOMETOZINE;
BREAST ENDOPROSTHESIS;
CARDIOVASCULAR RISK;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DEVICE;
DIABETES CONTROL;
DIABETES MELLITUS;
EXTRACORPOREAL OXYGENATION;
FIBRINOLYTIC THERAPY;
HEART FAILURE;
HUMAN;
INTERMITTENT POSITIVE PRESSURE VENTILATION;
MAMMOGRAPHY;
MEDICAL CARE;
MEDICAL LITERATURE;
OUTCOMES RESEARCH;
OXYGEN THERAPY;
PATIENT CARE;
PREDICTION;
PRIORITY JOURNAL;
RESPIRATORY FAILURE;
REVIEW;
SAFETY;
SILICONE PROSTHESIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
EID: 0033817724
PISSN: 00396060
EISSN: None
Source Type: Journal
DOI: 10.1067/msy.2000.107064 Document Type: Article |
Times cited : (5)
|
References (35)
|